BTAI: BioXcel Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 10.45
Enterprise Value ($M) 74.51
Book Value ($M) -85.63
Book Value / Share -27.61
Price / Book -0.12
NCAV ($M) -86.73
NCAV / Share -27.96
Price / NCAV -0.12

Profitability (mra)
Return on Invested Capital (ROIC) -3.67
Return on Assets (ROA) -0.96
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 1.81
Current Ratio 1.87

Balance Sheet (mrq) ($M)
Current Assets 47.79
Assets 48.89
Liabilities 134.53
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G Armistice Capital, Llc
12-18 13G Qatar Investment Authority 5.20
12-18 13G Oaktree Capital Group Holdings GP, LLC 5.20
09-10 13G/A Fmr Llc 2.64 -57.30
06-06 13D/A Bioxcel Corp 23.50 -7.09

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-03-22 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-10 391,495 1,438,094 27.22
2025-03-07 713,889 2,337,438 30.54
2025-03-06 321,464 1,022,413 31.44
2025-03-05 1,961,086 5,618,586 34.90

(click for more detail)

Similar Companies
BNTC – Benitec Biopharma Inc. BOLT – Bolt Biotherapeutics, Inc.
BON – Bon Natural Life Limited BYSI – BeyondSpring Inc.
CALC – CalciMedica, Inc.


Financial data and stock pages provided by
Fintel.io